Shots:
In this second installment of Dealmaker 2024, PharmaShots presents an insightful guide to the top M&A deals ranked by deal value
This report highlights Novo Nordisk’s remarkable achievements, including 24 collaborations spanning acquisitions, company formations, contract services, development and commercialization agreements, facility purchases, licensing options, and platform/product purchases. Collectively, these deals amount to a…
Shots:
The first dose of the J.P. Morgan Special: Dealmaker of the Year report based on the total number of deals signed in 2024
Last year, Roche inked 38 deals comprising acquisitions, contract services, development & commercialization, facility purchase, R&D, platform/product purchases, and sales/co-promotion
Leveraging DealForma’s invaluable insights, PharmaShots brings an on-demand report…
Shots:
The first dose of the J.P. Morgan Special: Dealmaker of the Year report based on the total number of deals signed in 2024
Last year, Roche inked 38 deals comprising acquisitions, contract services, development & commercialization, facility purchase, R&D, platform/product purchases, and sales/co-promotion
Leveraging DealForma’s invaluable insights, PharmaShots brings an on-demand report on the Dealmaker…

